AiON

Hot flushes caused by adjuvant endocrine therapy for breast cancer

Moderate to severe hot flushes caused by adjuvant endocrine therapy in women with breast cancer, a group who often cannot use hormone therapy. In the EU, elinzanetant is authorised for this indication; the FDA did not include it.

Institutional endorsement by Clínica Evolution

This entry is for information. Your case requires an individual medical assessment.